10 likes | 19 Views
Growing preference for minimally invasive surgeries coupled with increasing prevalence of chronic diseases such as gastrointestinal diseases, and cancer have attributed to the market growth.
E N D
Endoscopy Equipment Market: A Decade of Successes, Challenges, and Opportunities According to the deep-dive market assessment study conducted by Growth+ Reports, the global endoscopy equipment market was pegged at ~US$ 26.9 billion in 2021. The market is expected to witness a CAGR of ~7.10% from 2022 to 2030. Growing preference for minimally invasive surgeries coupled with increasing prevalence of chronic diseases such as gastrointestinal diseases, and cancer have attributed to the market growth. Increasing volume of endoscopic procedures, new product launches and technological advancements have also played a key role in boosting the endoscopy equipment market. However, higher cost of endoscopic procedures, limited reimbursement coverage and product recalls by FDA are restraining the market growth to a certain extent. To access the Sample PDF of this research study, please request here: https://growthplusreports.com/inquiry/request-sample/endoscopy-equipment-market/7643 Globally increasing geriatric population has a significant impact on endoscopy equipment demand because of their low tolerance to intervention, more vulnerability to diseases and health issues such as gastrointestinal problems, orthopedic diseases, cancer etc. The rise in popularity of minimally invasive and endoscopic procedures is creating huge opportunities for the growth of the endoscopy equipment market. Some of the prominent players operating in the Endoscopy Equipment Market includes: - •Olympus Corporation •Stryker •KARL STORZ SE & Co. KG •FUJIFILM Corporation •Medical Devices Business Services •Smith+Nephew •Boston Scientific Corporation •HOYA Corporation •Avante Health Solutions •STERIS •among others Browse the full report now: https://growthplusreports.com/report/endoscopy-equipment- market/7643 About Us: Growth+Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association). Growth+ portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis, and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success. We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.